Plasma rich in growth factors (PRGF) as a treatment for high ankle sprain in elite athletes: a randomized control trial

This report has been verified by one or more authors of the original publication.

この研究はハイインパクトの可能性があります。 OEのAI駆動型ハイインパクト指標は、論文が掲載されたジャーナルと論文自体の科学的内容の両方からのシグナルを統合することで、論文が持つ可能性の高い影響力を推定します。 最先端の自然言語処理を用いて開発されたOEハイインパクトモデルは、ジャーナルのインパクトファクターのみよりも、研究の将来の引用実績をより正確に予測します。 これにより、臨床的に意義のある研究をより早く認識することが可能になり、読者は将来の診療を形成する可能性が最も高い論文に集中することができます。

15 elite athletes (16 ankles) with grade 3 high ankle sprains, with complete anteroinferior tibiofibular ligament (AITFL) tears, were included in this study. The purpose of the study was to determine how ultrasound-guided platelet-rich in Growth Factor (PRGF) injections effect recovery, return to play, and dynamic stability in this injury. The results displayed that athletes who received PRGF injections had a significantly shorter return to play times and a lower number of patients returning to play with residual pain compared to the control group. Sonographic evaluations displayed no significant differences in the syndesmotic opening between groups up to 6 weeks post-injury. Further trials using larger sample size and a more generalizable patient population are warranted based on the results of this study.